tenoxicam
Small moleculeexperimental
Tenoxicam, sold under the brand name Mobiflex among others, is a nonsteroidal anti-inflammatory drug (NSAID). It is used to relieve inflammation, swelling, stiffness, and pain associated with rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, tendinitis, bursitis, and periarthritis of the shoulders or hips. — Wikipedia
Clinical trial activity
10 trials · 11 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
2
Phase 3
0
Phase 4
4
Earliest trial started Nov 1, 2014 (NCT02160236)
Timeline
Indications
Approved for
Mechanism of action
- CyclooxygenaseINHIBITOR
Cyclooxygenase inhibitor
Chemistry & pharmacology
Loading structure…
SMILES
CN1C(C(=O)Nc2ccccn2)=C(O)c2sccc2S1(=O)=O- Mol. weight
- 337.38 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaTenoxicam ↗
- ChEMBLCHEMBL302795 ↗
Also known as
- 4-hydroxy-2-methyl-n-2-pyridyl-2h-thieno(2,3-e)-1,2-thiazine-3-carboxamide 1,1-dioxide
- apo-tenoxicam
- artriunic
- mobiflex
- mobiflex
- mobiflex
- mobiflex
- novo-tenoxicam
- reutenox
- ro 12-0068
- ro-12-0068
- ro-120068000
- ro-120068000
- tenoxicam
- tenoxicam
- tenoxicam
- tenoxicam
- tenoxicam
- tenoxicam
- tenoxicam
- tenoxicam
- tenoxicam
- ténoxicam
- ténoxicam
- tenoxicamum
- tenoxicamum
- tilcotil
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07194135 | N/A | Nov 3, 2024 | Benha University |
| NCT06786650 | Phase 4 | May 15, 2024 | Haydarpasa Numune State Hospital |
| NCT06572904 | Phase 1/Phase 2 (Phase 2) | Feb 20, 2024 | Mansoura University |
| NCT05291793 | N/A | Apr 1, 2020 | Acibadem University, Nevsehir Haci Bektas Veli University |
| NCT04314310 | N/A | Mar 23, 2020 | National Taiwan University |
| NCT05497570 | Phase 1 | May 3, 2019 | Ataturk University |
| NCT04182191 | Phase 4 | Mar 1, 2018 | University of Sao Paulo |
| NCT02549118 | Phase 2 | Sep 1, 2015 | Ain Shams University |
| NCT02160236 | Phase 4 | Nov 1, 2014 | Erciyes University |
| NCT02285972 | Phase 4 | Nov 1, 2014 | T.C. Ordu Universitesi |
Showing 10 of 10 trials
Page 1 / 1
Organizations
Research & Development (11)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Acibadem University | Academic/Hospital | 1 | 0 | 1 | 2020 |
| Ain Shams University | Academic/Hospital | 1 | 1 | 1 | 2015 |
| Ataturk University | Academic/Hospital | 1 | 1 | 1 | 2019 |
| Benha University | Academic/Hospital | 1 | 1 | 1 | 2024 |
| Erciyes University | Academic/Hospital | 1 | 1 | 1 | 2014 |
| Haydarpasa Numune State Hospital | Academic/Hospital | 1 | 1 | 1 | 2024 |
| Mansoura University | Academic/Hospital | 1 | 1 | 1 | 2024 |
| National Taiwan University | Academic/Hospital | 1 | 1 | 1 | 2020 |
| Nevsehir Haci Bektas Veli University | Academic/Hospital | 1 | 1 | 1 | 2020 |
| T.C. Ordu Universitesi | Academic/Hospital | 1 | 1 | 1 | 2014 |
| University of Sao Paulo | Academic/Hospital | 1 | 1 | 1 | 2018 |
11 organizations
Page 1 / 1